Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis

Cell Death and Differentiation

Volumn 15, Issue 1, 2008, Pages 183-191

  Schiller, M ^a   Bekeredjian Ding, I ^a   Heyder, P ^a   Blank, N ^a   Ho, A D ^a   Lorenz, H M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOCHROME C; DNA; GENE PRODUCT; HEAT SHOCK PROTEIN 70; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; LAMIN B; NUCLEAR MATRIX PROTEIN; PHOSPHATIDYLSERINE; PROHIBITIN; PROTEIN P53; RIBONUCLEOPROTEIN; RNA;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MEMBRANE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DEGRADATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYMPHOBLAST; PARTICLE SIZE; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; CELLS, CULTURED; CYTOPLASM; CYTOPLASMIC VESICLES; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; PHAGOCYTES;

EID: 37349104035     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402239     Document Type: Article

References (38)

1. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 2006; 9: 1173-187.
2. Liu G, Wu C, Wu Y, Zhao Y. Phagocytosis of apoptotic cells and immune regulation. Scand J Immunol 2006; 64: 1-9.
3. Lorenz HM, Grunke M, Hieronymus T, Winkler S, Blank N, Rascu A et al. Hyporesponsiveness to gammac-chain cytoldnes in activated lymphocytes from patients with systemic lupus erythematosus leads-to accelerated apoptosis. Eur J Immunol 2002; 32: 1253-1263.
4. White S, Rosen A. Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol 2003; 15: 557-562.
5. Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnell A, Manger B et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthitis Rheum 1997; 40: 306-317.
6. Pemiok A, Wedekind F, Hermmann M, Specker C, Schneider M. Aigh levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998: 7: 113-118.
7. Licht R, Dieker JW, Jacobs CW, Tax WJ, Barden JH, Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 2004; 22 139-145.
8. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-defived macrophages from patients. with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1121-1250.
9. Gabler C, Blank N, Hieronymus T, Schiller M, Berden JH, Kalden JR et al. Extranuclear detection of histones and nuclesomes in activated-human lymphoblasts as an early event in apoptosis. Ann Rheum Dis 2004; 63: 1135-1144.
10. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172: 6692-6700.
11. Frisoni L, McPhie L, Colonna L, Sriram U, Monestier M, Gallucci S et al. Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens; a novel pathogenic pathway for autoimmunity? J Immunol 2005; 175: 2692-2701.
12. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005; 52 3337-3348.
13. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: Two sides of the coin. Physiology (Bethesda) 2005; 20: 22-27.
14. Pilzer D, Gasser O, Moskovich O, Schifferli JA, Fishelson Z. Emission of membrane vesicles: Roles in complement resistance, immunity and cancer. Springer Semin Immunopathol 2005; 27: 375-387.
15. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002; 3: 1156-1162.
16. Segura E, Guerin C, Hogg N, Amigorena S, Thery C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vitro. J Immunol 2007; 179: 1489-1496.
17. Cocca BA, Cline AM, Radic MZ. Blebs and apoptotic bodies are B cell autoantigens. J Immunol 2002; 169: 159-166.
18. Sebbagh M, Hamelin J, Bertoglio J, Solary E, Breard J. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med 2005; 201: 465-471.
19. Orlando KA, Stone NL, Pittman RN. Rho kinase regulates fragmentation and phagocytosis of apoptotic cells. Exp Cell Res 2006; 312: 5-15.
20. Lane JD, Alan VJ, Woodman PG. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J Cell Sci 2005; 118: 4059-4071.
21. Cline AM, Radic MZ. Apoptosis, suboellular particles, and autoimmunity. Clin Immunol 2004; 112: 175-182.
22. Fadeel B. Plasma membrane alterations during apoptosis: Role in corpse clearance. Antioxid Redox Signal 2004; 6: 269-275.
23. Geske FJ, Monks J, Lehman L, Fadok VA. The role of the macrophage in apoptosis: Hunter, gatherer, and regulator. Int J Hematol 2002; 76: 16-26.
24. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cels. Nature 1997; 390 350-351.
25. Gabler C, Kalden JR, Lorenz HM. The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus Erythematosus. Biochem Pharmacol 2003; 66: 1441-1446.
26. Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 2003; 113: 507-517.
27. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-519.
28. Marchetti P, Hirsch T, Zamzami N, Castedo M, Decaudin D, Susin SA et al. Mitochondrial permeability transition, triggers lymphocyte apoptosis. J Immunol 1996; 157: 4830-4836.
29. Martin S, Tesse A, Hugel B, Martinez MC, Morel O, Freyssinet JM et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 2004; 109: 1653-1659.
30. Qian Y, Wang H, Clarke SH. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol 2004; 172: 625-635.
31. Radic MZ, Shah K, Zhang W, Lu Q, Lemke G, Hilliard GM. Heterogeneoss nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases. J Immunol 2006; 176: 68-74.
32. Heyder P, Bekeredjian-Ding I, Parcina M, Blank N, Ho AD, Herrmann M et al. Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha. Autoimmunity 2007; 40: 331-332.
33. Lorenz HM, Hieronymus T, Grunke M, Manger B, Kalden JR. Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lyphocytes. Scand J Immunol 1997; 45: 660-669.
34. Hieronymus T, Blank N, Gruenke M, Winkler S, Haas JP, Kalden JR et al. CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes. Cell Death Differ 2000; 7: 538-547.
35. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J et al. Proteomic analysis of dendritic cell-dedved exosomes: A secreted subcellular compartment disfinct from apoptotic vesicles. J Immunol 2001; 166: 7309-7318.
36. Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumalology (Oxfprd) 2005; 44: 975-982.
37. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-279.
38. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 64: 1415-1420.